Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis

Lancet Microbe, The - Tập 2 Số 9 - Trang e450-e460 - 2021
Kristin L. Andrejko1, Buddhika Ratnasiri2, William P. Hausdorff3,4, Ramanan Laxminarayan5,6, Joseph A. Lewnard7,1,8
1Division of Epidemiology, School of Public Health, University of California, Berkeley, CA, USA
2College of Letters and Science, University of California, Berkeley, CA, USA
3Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium
4PATH, Washington, DC, USA
5Center for Disease Dynamics, Economics and Policy, New Delhi, India
6High Meadows Environmental Institute, Princeton University, Princeton, NJ, USA
7Center for Computational Biology, College of Engineering, University of California, Berkeley, CA, USA
8Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bogaert, 2004, Streptococcus pneumoniae colonisation: the key to pneumococcal disease, Lancet Infect Dis, 4, 144, 10.1016/S1473-3099(04)00938-7

Walker, 2013, Global burden of childhood pneumonia and diarrhoea, Lancet, 381, 1405, 10.1016/S0140-6736(13)60222-6

Buckley, 2019, Impact of vaccination on antibiotic usage: a systematic review and meta-analysis, Clin Microbiol Infect, 25, 1213, 10.1016/j.cmi.2019.06.030

Lewnard, 2020, Childhood vaccines and antibiotic use in low- and middle-income countries, Nature, 581, 94, 10.1038/s41586-020-2238-4

Evans, 1963, Tetracycline-resistant pneumococcus, Lancet, 281, 451, 10.1016/S0140-6736(63)92350-X

Sader, 2019, Antimicrobial susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific region: results from 20 years of the SENTRY antimicrobial surveillance program (1997–2016), Open Forum Infect Dis, 6, S14, 10.1093/ofid/ofy263

Hausdorff, 2000, Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I, Clin Infect Dis, 30, 100, 10.1086/313608

Kyaw, 2006, Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae, N Engl J Med, 354, 1455, 10.1056/NEJMoa051642

Song, 2012, The relationship between pneumococcal serotypes and antibiotic resistance, Vaccine, 30, 2728, 10.1016/j.vaccine.2012.01.091

Dagan, 2008, Impact of conjugate pneumococcal vaccines on antibiotic resistance, Lancet Infect Dis, 8, 785, 10.1016/S1473-3099(08)70281-0

Feikin, 2013, Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites, PLoS Med, 10, 10.1371/journal.pmed.1001517

Huang, 2009, Continued impact of pneumococcal conjugate vaccine on carriage in young children, Pediatrics, 124, e1, 10.1542/peds.2008-3099

Fenoll, 2009, Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007, J Clin Microbiol, 47, 1012, 10.1128/JCM.01454-08

Van Effelterre, 2010, A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination, Vaccine, 28, 3650, 10.1016/j.vaccine.2010.03.030

Sevilla, 2018, Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR, Proc Natl Acad Sci USA, 115, 12911, 10.1073/pnas.1717161115

Troeger, 2017, Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015, Lancet Infect Dis, 17, 909, 10.1016/S1473-3099(17)30276-1

Lipsitch, 2016, How can vaccines contribute to solving the antimicrobial resistance problem?, MBio, 7, 1, 10.1128/mBio.00428-16

Huang, 2005, Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004, Pediatrics, 116, e408, 10.1542/peds.2004-2338

Cizman, 2001, The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens, J Antimicrob Chemother, 47, 475, 10.1093/jac/47.4.475

Vaz, 2014, Recent trends in outpatient antibiotic use in children, Pediatrics, 133, 375, 10.1542/peds.2013-2903

Dagan, 2009, Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population, J Infect Dis, 199, 776, 10.1086/597044

Navarro-Torné, 2015, Risk factors for death from invasive pneumococcal disease, Europe, 2010, Emerg Infect Dis, 21, 417, 10.3201/eid2103.140634

Friedland, 1992, Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis, Lancet, 339, 405, 10.1016/0140-6736(92)90087-J

Zapalac, 2002, Suppurative complications of acute otitis media in the era of antibiotic resistance, Arch Otolaryngol Head Neck Surg, 128, 660, 10.1001/archotol.128.6.660

Mathur, 2018, Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review, Paediatr Int Child Health, 38, S66, 10.1080/20469047.2017.1409455

Bradley, 2011, The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, Clin Infect Dis, 53, e25, 10.1093/cid/cir531

Sharland, 2018, Classifying antibiotics in the WHO Essential Medicines List for optimal use-be AWaRe, Lancet Infect Dis, 18, 18, 10.1016/S1473-3099(17)30724-7

Ginsburg, 2017, Vaccination to reduce antimicrobial resistance, Lancet Glob Health, 5, e1176, 10.1016/S2214-109X(17)30364-9

Thông tin
Thông tin xuất bản

Lancet Microbe, The

Tập 2 Số 9

e450-e460

Thông tin tác giả